000 02384nam a22003737a 4500
008 210628s20212021 xxu||||| |||| 00| 0 eng d
022 _a2211-0348
024 _a10.1016/j.msard.2021.103011 [doi]
024 _aS2211-0348(21)00278-9 [pii]
040 _aOvid MEDLINE(R)
099 _a34015641
245 _aConus involvement and leptomeningeal enhancement in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: A case report.
251 _aMultiple Sclerosis and Related Disorders. 52:103011, 2021 May 07.
252 _aMult Scler Relat Disord. 52:103011, 2021 May 07.
253 _aMultiple sclerosis and related disorders
260 _c2021
260 _fFY2021
260 _p2021 May 07
265 _saheadofprint
266 _d2021-06-28
520 _aThere are a variety of clinical phenotypes and radiological features that continue to make a diagnosis of neuromyelitis optica spectrum disorder (NMOSD) challenging. We present an atypical case of an adult woman who presented with flaccid paralysis of all extremities with unusual neuroimaging features, including extensive enhancing lesions in the upper cervical cord and conus medullaris with associated leptomeningeal enhancement. She was ultimately found to have AQP4 antibody-positive NMOSD. We discuss the factors that complicated a timely diagnosis, including her atypical radiographic features and an initially negative cell-based assay for myelin oligodendrocyte glycoprotein (MOG) and aquaporin-4 (AQP4) antibodies. Despite the rarity of conus medullaris involvement or leptomeningeal enhancement in AQP4 antibody-positive NMOSD, it is important to maintain a high level of clinical suspicion to avoid diagnostic and therapeutic delays. Though cell-based assays have high sensitivities, testing should be repeated on negative values in these scenarios. Copyright (c) 2021 Elsevier B.V. All rights reserved.
546 _aEnglish
650 _aIN PROCESS -- NOT YET INDEXED
651 _aMedStar Washington Hospital Center
656 _aNeurology
656 _aNeurology Residency
657 _aLetter
700 _aHu, Nancy
700 _aMyers, Cory
700 _aSafadi, Amy
790 _aHu NN, Myers CJ, Osborne B, Safadi AL
856 _uhttps://dx.doi.org/10.1016/j.msard.2021.103011
_zhttps://dx.doi.org/10.1016/j.msard.2021.103011
942 _cART
_dArticle
999 _c6417
_d6417